Orris

Vzv transverse myelitis and steroids ...can they be given

Reading File
VZV transverse myelitis is a rare but serious complication of varicella-zoster virus infection. Steroids are controversial in this setting - the concern is that immunosuppression could worsen a viral infection, but inflammation itself drives much of the cord damage. Generally, antivirals (IV acyclovir) are the cornerstone, and steroids may be used adjunctively in selected cases.
Searching sources...
Finding Sources
Searching PubMed

varicella zoster transverse myelitis treatment steroids acyclovir

Good - I have relevant hits. Let me read the key sections from Adams & Victor's neurology textbook and Harrison's, plus get the recent 2025 case report details.
Reading File
Finding Sources
Reading Article

PMID: 40792232

Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web

VZV varicella zoster transverse myelitis corticosteroids treatment guidelines 2024

Excellent - I now have very good data from the Hopkins ABX Guide, the Cureus 2025 case, and the PMC case series. Let me read the Rosen's transverse myelitis section for the full steroid context.
Reading File
I now have comprehensive information to give a thorough answer. Here is a synthesis:

VZV Transverse Myelitis: Can Steroids Be Given?

Short answer: Yes, but only as adjunctive therapy alongside IV acyclovir - not as monotherapy.

Pathophysiology (Why This Question Matters)

VZV myelitis has two distinct mechanisms:
  1. Direct viral invasion of the cord - virus replicates in anterior horn cells or spreads from dorsal root ganglia into adjacent cord
  2. Post-infectious / parainfectious immune-mediated inflammation - the cord damage is driven by the host immune response rather than active virus replication
The mechanism matters because:
  • Direct invasion: antivirals are the priority; steroids theoretically risk worsening viral spread
  • Post-infectious: steroids can suppress the immune-mediated cord damage and are more clearly beneficial
In practice, both mechanisms can coexist or be hard to distinguish clinically, which is why combined antiviral + steroid therapy is used.

First-Line Treatment

IV Acyclovir is the cornerstone:
  • Acyclovir 10 mg/kg IV every 8 hours x 7 days (minimum)
  • Extend duration in immunocompromised patients
  • Confirm or exclude active VZV with CSF PCR before committing to the regimen

Role of Corticosteroids

Yes, steroids can and should be used - but adjunctively:
The Johns Hopkins ABX Guide (2024) specifically recommends for VZV myelitis:
Acyclovir 10 mg/kg IV q8h x 7 days + prednisone 60-80 mg PO daily x 3-5 days
The rationale for adding steroids:
  • VZV is known to cause vascular inflammation in CNS tissue (vasculopathy component)
  • Steroids reduce this neuroinflammation and may limit further cord injury
  • Multiple case reports and series show neurological improvement with combined therapy
Dosing options used in practice:
ApproachDoseDuration
Oral prednisone (mild-moderate)60-80 mg/day PO3-5 days
IV methylprednisolone pulse (severe)1 g/day IV3-5 days
Low-dose IVMP (as adjunct, immunocompromised)40-60 mg/day IVShort course
A 2025 Cureus case report (PMID 40486416) of VZV myelitis with thoracic demyelination in an HIV patient showed "notable neurological improvement following initiation of corticosteroids" alongside ganciclovir, and concluded: "adjunctive corticosteroid therapy may reduce inflammation and improve outcomes in VZV myelitis."
The 2025 IDCases report (PMID 40792232) used IV corticosteroid pulse + ganciclovir + plasma exchange in an SLE/VZV overlap case, resulting in partial recovery.

Important Caveats

  1. No randomized controlled trials exist - evidence is entirely from case reports, case series, and expert opinion. The Rosen's Emergency Medicine textbook notes: "There are no good studies supporting a role for steroids" for transverse myelitis in general, though NMOSD-related TM is an exception where steroids are clearly indicated.
  2. Never give steroids alone (monotherapy) in confirmed VZV myelitis - this risks suppressing viral clearance.
  3. Immunocompromised patients (HIV, SLE, transplant): Extra caution is needed. Antiviral coverage must be aggressive. Steroids are used but with close monitoring for viral dissemination.
  4. Distinguish from NMOSD/anti-AQP4 myelitis - if aquaporin-4 antibodies or MOG antibodies are positive, high-dose steroids are the primary treatment, not just adjunctive.
  5. Plasma exchange (PLEX) is considered second-line if there is no response to steroids + antivirals.

Summary Algorithm

Suspected VZV Transverse Myelitis
         |
         v
MRI spine + LP (CSF VZV PCR, cell count, protein)
         |
         v
Start IV Acyclovir immediately (don't wait for PCR result)
         |
         v
Add corticosteroids as adjunct:
  - Mild/moderate: Prednisone 60-80 mg/day PO x 3-5 days
  - Severe: Methylprednisolone 1 g/day IV x 3-5 days
         |
         v
No improvement in 5-7 days?
  → Consider PLEX
  → Recheck diagnosis (NMOSD? MOG-AD?)
Bottom line: Steroids are appropriate in VZV transverse myelitis as adjunctive therapy - they target the inflammatory/vascular component of cord injury. They must always be paired with adequate antiviral cover (IV acyclovir). The evidence base is observational only, but the combination is supported by the Hopkins ABX Guide and multiple recent case series.
  • Adams & Victor's Principles of Neurology, 12th Edition - Viral Myelitis chapter
  • Rosen's Emergency Medicine - Transverse Myelitis section, p. 2044
  • Johns Hopkins ABX Guide, Myelitis (Auwaerter, 2024)
This is a shared conversation. Sign in to Orris to start your own chat.